Rocket Pharmaceuticals, Inc.
← Back to RCKT Overview

Rocket Pharmaceuticals, Inc. (RCKT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.13

Financial Fundamentals

RCKTQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-12-31-6.38
2014-03-31-5.88
2014-06-30-4.44
2014-09-30-5.26
2014-12-31-5.88
2015-03-31-7.13
2015-06-30-8.45
2015-09-30-0.95
2015-12-31-9.14
2016-03-31-4.87
2016-06-30-5.72
2016-09-30-5.75
2016-12-31-3.18
2017-03-31-1.27
2017-06-30-1.96
2017-09-30-1.63
2017-12-31-3.63
2018-03-31-11.16
2018-06-30-12.27
2018-09-30-14.71
2018-12-31-6.07
2019-03-31-10.26
2019-06-30-9.19
2019-09-30-7.66
2019-12-31-15.81
2020-03-31-7.75
2020-06-30-11.63
2020-09-30-10.78
2020-12-31-12.46
2021-03-31-17.07
2021-06-30-20.13
2021-09-30-9.46
2021-12-31-7.91
2022-03-31-5.92
2022-06-30-4.14
2022-09-30-4.64
2022-12-31-5.56
2023-03-31-6.21
2023-06-30-6.06
2023-09-30-6.83
2023-12-31-11.71
2024-03-31-10.12
2024-06-30-6.98
2024-09-30-6.50
2024-12-31-5.07
2025-03-31-2.98
2025-06-30-0.99
2025-09-30-1.81
2025-12-31-2.31
2026-03-31-2.13

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Rocket Pharmaceuticals, Inc. (RCKT) P/E Ratio History & Valuation Cycles